Christina Ehrhardt

Title: Christina Ehrhardt: Innovator in Anti-Infective Strategies

Introduction

Christina Ehrhardt is a prominent inventor based in Muenster, Germany. She has made significant contributions to the field of anti-infective strategies, particularly in relation to influenza virus and co-infections. With a total of 3 patents to her name, her work is paving the way for new treatment methodologies.

Latest Patents

Ehrhardt's latest patents focus on a novel anti-infective strategy against the influenza virus and co-infections. The inventions relate to the use of MEK inhibitors, p38 inhibitors, and/or NFκB inhibitors for the prophylaxis and treatment of co-infections that involve bacterial infections alongside influenza virus infections. Additionally, her patents include compositions that utilize these inhibitors for effective treatment. An in vitro test system is also provided, which comprises cultured cells infected with either the influenza virus and a bacterium or with a bacterium alone.

Career Highlights

Throughout her career, Christina has worked with notable organizations such as Atriva Therapeutics GmbH and Westfälische Wilhelms-Universität Münster. Her research and innovations have garnered attention in the scientific community, contributing to advancements in medical treatments.

Collaborations

Ehrhardt has collaborated with esteemed colleagues, including Stephan Ludwig and Eike-Roman Hrincius. These partnerships have further enhanced her research and development efforts in the field of anti-infective strategies.

Conclusion

Christina Ehrhardt's innovative work in developing anti-infective strategies against influenza and bacterial co-infections showcases her dedication to advancing medical science. Her contributions are vital in the ongoing fight against infectious diseases.